Mecure

Menu


About us

about us

About Us

Me Cure is a leading human therapeutics company in the pharmaceutical industry in Lagos, Nigeria. For more than a decade, the company has tapped the power of new technology and innovation to advance the practice of medicine.

Me Cure pioneered the development of novel products based on advances in technology and launched the pharmaceutical industry’s first tablet in a capsule formulation called Liquitab Floatcap. Today, as a leading healthcare company serving millions of patients, Me Cure continues to be an entrepreneurial, technology‐driven enterprise dedicated to helping people fight everyday illness.

Our manufacturing network is continuously optimized so that our customers can have full confidence in our supply chain. This is enabled by high-volume, technologically-advanced distribution facilities. These facilities allow us to deliver new products swiftly and reliably. We continually review our capabilities and capacity. This ensures that we can consistently deliver best-in-class products. Our customers know that their end-consumers are receiving high-quality healthcare and wellness pharmaceuticals.

The core and success of our continuous drive for excellence is expressed in the values of our global team. Their commitment and sense of responsibility are derived from the awareness that every product that we make will affect another person’s health. And health is the cornerstone of our dedication to making life better.

Me Cure, is committed to supporting initiatives that improve the communities where we operate, provide better access to care for patients, and improve patient outcomes by supporting research that will advance scientific knowledge about our products to generate new medical interventions.

Me Cure's Quality Control (QC) team ensures the delivery of high standard products by conducting step by step review. QC, as a centre of excellence, ensures compliance and follows systematic interventions like streamlining SOPs around critical quality parameters, bullet-proofing complex procedures and targeted capacity building.